Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 8170
Gene Symbol: SLC14A2
SLC14A2
0.010 Biomarker disease BEFREE Based on our findings, our current model suggests that in HA cases where the F8 gene is normal and is predicted to express normal levels of FVIII, F8 mRNA 3' UTR targeting miRNAs may be responsible for a FVIII-deficiency phenotype clinically manifesting as HA. 31785023 2020
Entrez Id: 2837
Gene Symbol: UTS2R
UTS2R
0.010 Biomarker disease BEFREE Based on our findings, our current model suggests that in HA cases where the F8 gene is normal and is predicted to express normal levels of FVIII, F8 mRNA 3' UTR targeting miRNAs may be responsible for a FVIII-deficiency phenotype clinically manifesting as HA. 31785023 2020
Entrez Id: 7001
Gene Symbol: PRDX2
PRDX2
0.010 Biomarker disease BEFREE Although the degree of scientific evidence of the publications on intra-articular injections of various drugs (hyaluronic acid, corticosteriods, PRP and MSCs) in haemophilia is very low, it seems that intra-articular injections of hyaluronic acid can relieve joint pain for months and can be repeated every 6-12 months, which is why they can be recommended. 31639263 2019
Entrez Id: 4153
Gene Symbol: MBL2
MBL2
0.010 Biomarker disease BEFREE Investigation of the association between the inhibitor development in hemophilia A and MBL2-SNPs. 31141731 2019
Entrez Id: 79092
Gene Symbol: CARD14
CARD14
0.010 Biomarker disease BEFREE Although the degree of scientific evidence of the publications on intra-articular injections of various drugs (hyaluronic acid, corticosteriods, PRP and MSCs) in haemophilia is very low, it seems that intra-articular injections of hyaluronic acid can relieve joint pain for months and can be repeated every 6-12 months, which is why they can be recommended. 31639263 2019
Entrez Id: 1436
Gene Symbol: CSF1R
CSF1R
0.010 GeneticVariation disease BEFREE We confirmed an association of CSF1R rs17725712 and MAPK9 rs4147385 with inhibitor development in haemophilia A patients in North China. 31149782 2019
Entrez Id: 695
Gene Symbol: BTK
BTK
0.010 Biomarker disease BEFREE Prevention of the anti-factor VIII memory B-cell response by inhibition of Bruton tyrosine kinase in experimental hemophilia A. 30545924 2019
Entrez Id: 9332
Gene Symbol: CD163
CD163
0.010 AlteredExpression disease BEFREE Haemophilia monocytes express reduced amounts of the receptors for M-CSF and GM-CSF, which correlates with a failure to express tumour necrosis factor α (TNFα) and CD163 in M-CSF-treated haemophilia macrophages and reduced expression of TNFα and CD206 after treatment with GM-CSF. 30650445 2019
Entrez Id: 1437
Gene Symbol: CSF2
CSF2
0.010 Biomarker disease BEFREE We show here that macrophage polarization is deregulated in haemophilia in response to macrophage colony-stimulating factor (M-CSF) and partially in response to granulocyte-macrophage colony-stimulating factor (GM-CSF). 30650445 2019
Entrez Id: 5978
Gene Symbol: REST
REST
0.010 AlteredExpression disease BEFREE On the other hand, the statistical analysis using REST software indicated that the expression of NONHSAT139219 and NONHSAT139215 in severe HA patients was significantly down-regulated as compared to control group (p < .05). 30758269 2019
Entrez Id: 2160
Gene Symbol: F11
F11
0.010 Biomarker disease BEFREE Hemostatic defect of patients with deficient MP-mediated coagulation resembles deficiency of FXI (hemophilia C), distinct from hemophilia A or B, so can be termed type C hemostasis. 31195421 2019
Entrez Id: 51156
Gene Symbol: SERPINA10
SERPINA10
0.010 Biomarker disease BEFREE Gene-deletion of PZ or ZPI improves coagulation in hemophilia (FVIII knockout) mice. 30451376 2019
Entrez Id: 55364
Gene Symbol: IMPACT
IMPACT
0.010 GeneticVariation disease BEFREE Adults with self-reported hemophilia A or B completed the cross-sectional IMPACT QoL II survey. 31571840 2019
Entrez Id: 100616406
Gene Symbol: MIR4521
MIR4521
0.010 Biomarker disease BEFREE A sensitive and selective electrochemical method for simultaneous detection of two hemophilia A-related microRNAs (miR-1246 and miR-4521) was developed. 31708034 2019
Entrez Id: 722
Gene Symbol: C4BPA
C4BPA
0.010 Biomarker disease BEFREE Although the degree of scientific evidence of the publications on intra-articular injections of various drugs (hyaluronic acid, corticosteriods, PRP and MSCs) in haemophilia is very low, it seems that intra-articular injections of hyaluronic acid can relieve joint pain for months and can be repeated every 6-12 months, which is why they can be recommended. 31639263 2019
Entrez Id: 4360
Gene Symbol: MRC1
MRC1
0.010 Biomarker disease BEFREE Protein expression in response to M-CSF was regained with respect to CD163 and CD206 after embedding haemophilia monocytes in clotted plasma suggesting that a functioning coagulation system has positive effects on macrophage M2 polarization. 30650445 2019
Entrez Id: 3383
Gene Symbol: ICAM1
ICAM1
0.010 Biomarker disease BEFREE The MOEDs soluble intercellular adhesion molecule-1 (<i>p</i> = 0.0095) and interleukin-6 (<i>p</i> = 0.010) were significantly higher for patients with haemophilia compared with the control group. 30300903 2019
Entrez Id: 10058
Gene Symbol: ABCB6
ABCB6
0.010 Biomarker disease BEFREE Although the degree of scientific evidence of the publications on intra-articular injections of various drugs (hyaluronic acid, corticosteriods, PRP and MSCs) in haemophilia is very low, it seems that intra-articular injections of hyaluronic acid can relieve joint pain for months and can be repeated every 6-12 months, which is why they can be recommended. 31639263 2019
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.010 Biomarker disease BEFREE The MOEDs soluble intercellular adhesion molecule-1 (<i>p</i> = 0.0095) and interleukin-6 (<i>p</i> = 0.010) were significantly higher for patients with haemophilia compared with the control group. 30300903 2019
Entrez Id: 5270
Gene Symbol: SERPINE2
SERPINE2
0.010 Biomarker disease BEFREE Thromboelastometry studies showed enhanced clot stability and lengthened clot lysis time in blood from F8-/-/PN-1-/- and from patients with hemophilia A incubated with a PN-1-neutralizing antibody compared with their respective controls. 31383642 2019
Entrez Id: 3815
Gene Symbol: KIT
KIT
0.010 Biomarker disease BEFREE Two thirds of HA mice that received 2bF8 lentivirus-transduced HSCs under (CD45.2+CD117)-targeting ADC conditioning maintained sustained therapeutic levels of platelet FVIII expression. 31515232 2019
Entrez Id: 90865
Gene Symbol: IL33
IL33
0.010 Biomarker disease BEFREE In the hemophilia mouse model, hemarthrosis resulted in local cytokine/chemokine changes, represented by elevated pro-inflammatory (IL-6, MCP-1, MIP-1α, MIP-1β) and pro-angiogenic (VEGF and IL-33) cytokines, and decreased anti-pro-inflammatory cytokines IL-4 and IL-10. 31129747 2019
Entrez Id: 22943
Gene Symbol: DKK1
DKK1
0.010 Biomarker disease BEFREE The role of sclerostin/dickkopf-1 and receptor activator of nuclear factor kB ligand/osteoprotegerin signalling pathways in the development of osteoporosis in patients with haemophilia A and B: A cross-sectional study. 29194852 2018
Entrez Id: 50964
Gene Symbol: SOST
SOST
0.010 Biomarker disease BEFREE Patients with severe haemophilia had lower sclerostin concentrations compared with those with mild or moderate disease. 29194852 2018
Entrez Id: 4035
Gene Symbol: LRP1
LRP1
0.010 Biomarker disease BEFREE Collectively, these results provide new insights into the role of Breg cells and LPR/CD91 in the development of inhibitors in patients with hemophilia A. 28393618 2018